Journal Mobile Options
Table of Contents
Vol. 104, No. 4, 2013
Issue release date: November 2013
Neonatology 2013;104:298-304

Risk Factors and Correlates of Neonatal Growth Velocity in Extremely Low Gestational Age Newborns. The ELGAN Study

Bartholomew J. · Martin C.R. · Allred E. · Chen M.L. · Ehrenkranz R.A. · Dammann O. · Leviton A.
aDivision of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, bDepartment of Neonatology Beth Israel Deaconess Medical Center, cNeuroepidemiology Unit, Children's Hospital, dDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Mass., and eDivision of Perinatal Medicine, Department of Pediatrics, Yale University School of Medicine, New Haven, Conn., USA; fPerinatal Neuroepidemiology Unit, Hannover Medical School, Hannover, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objectives: To identify maternal and infant characteristics associated with reduced growth velocity (GV) in extremely premature newborns. Methods: We evaluated 1,187 infants born between 23 and 27 weeks' gestation at 14 institutions between 2002 and 2004 who survived until day 28 to identify the maternal and infant characteristics associated with a GV and caloric intake in the lowest quartile. Results: Newborns in the lowest gestational age and low birth weight categories, as well as those with intrauterine growth restriction, or high SNAP-II received relatively fewer kcal/kg/day than their peers without these risk factors, but were not at increased risk of being in the lowest GV quartile. Newborns with bacteremia, patent ductus arteriosus, retinopathy of prematurity stage 3-5, or pulmonary illness received fewer calories, as did those who received medications or blood transfusions. However, in a multivariable model adjusting for confounders, only ventilator dependence on day 7 (OR 2.2, 95% CI 1.5-3.2), early persistent pulmonary dysfunction (OR 1.8, 95% CI 1.3-2.5), and postnatal exposure to dexamethasone (OR 2.8, 95% CI 1.2-6.5) were associated with an increased risk of being in the lowest GV quartile. In this model, low caloric intake was not associated with low GV (OR 1.3, 95% CI 0.9-1.9). Conclusion: Variables associated with severe pulmonary disease convey more information about the risk of reduced GV during the first 28 postnatal days than does low caloric intake. © 2013 S. Karger AG, Basel

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Ehrenkranz RA, Younes N, Lemons JA, et al: Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999;104:280-289.

    External Resources

  2. Latal-Hajnal B, von Siebenthal K, Kovari H, Bucher HU, Largo RH: Postnatal growth in VLBW infants: significant association with neurodevelopmental outcome. J Pediatr 2003;143:163-170.
  3. Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, Poole WK: Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006;117:1253-1261.
  4. Casey PH, Whiteside-Mansell L, Barrett K, Bradley RH, Gargus R: Impact of prenatal and/or postnatal growth problems in low birth weight preterm infants on school-age outcomes: an 8-year longitudinal evaluation. Pediatrics 2006;118:1078-1086.
  5. Olsen IE, Richardson DK, Schmid CH, Ausman LM, Dwyer JT: Intersite differences in weight growth velocity of extremely premature infants. Pediatrics 2002;110:1125-1132.
  6. Wilson DC, Cairns P, Halliday HL, Reid M, McClure G, Dodge JA: Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997;77:F4-F11.
  7. Pointdexter B: Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcomes. J Pediatr 2006;148:6.
  8. Martin CR, Brown YF, Ehrenkranz RA, et al: Nutritional practices and growth velocity in the first month of life in extremely premature infants. Pediatrics 2009;124:649-657.
  9. Loui A, Tsalikaki E, Maier K, Walch E, Kamarianakis Y, Obladen M: Growth in high risk infants <1,500 g birthweight during the first 5 weeks. Early Hum Dev 2008;84:645-650.
  10. O'Shea TM, Allred EN, Dammann O, et al: The ELGAN Study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev 2009;85:719-725.
  11. Yudkin PL, Aboualfa M, Eyre JA, Redman CW, Wilkinson AR: New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 1987;15:45-52.
  12. Laughon M, Allred EN, Bose C, et al: Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 2009;123:1124-1131.
  13. The Committee for the Classification of Retinopathy of Prematurity: An international classification of retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-1134.
  14. Bloom BT, Mulligan J, Arnold C, et al: Improving growth of very low birth weight infants in the first 28 days. Pediatrics 2003;112:8-14.

    External Resources

  15. Gibson AT, Pearse RG, Wales JK: Growth retardation after dexamethasone administration: assessment by knemometry. Arch Dis Child 1993;69:505-509.
  16. Doyle LW, Ehrenkranz RA, Halliday HL: Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 2010;98:289-296.
  17. Bosco JL, Silliman RA, Thwin SS, et al: A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol 2010;63:64-74.
  18. Bohrer B, Silveira RC, Neto EC, Procianoy RS: Mechanical ventilation of newborns infant changes in plasma pro- and anti-inflammatory cytokines. J Pediatr 2010;156:16-19.
  19. Bose CL, Laughon MM, Allred EN, et al: Systemic inflammation associated with mechanical ventilation among extremely preterm infants. Cytokine 2013;61:315-322.
  20. Walker MG, Yao LJ, Patterson EK, et al: The effect of tidal volume on systemic inflammation in acid-induced lung injury. Respiration 2011;81:333-342.
  21. Hillman NH, Polglase GR, Pillow JJ, Saito M, Kallapur SG, Jobe AH: Inflammation and lung maturation from stretch injury in preterm fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011;300:L232-L241.
  22. Vento M, Moro M, Escrig R, et al: Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009;124:e439-e449.
  23. Oh W: Renal function and fluid therapy in high risk infants. Biol Neonate 1988;53:230-236.
  24. Shields B, Wacogne I, Wright CM: Weight faltering and failure to thrive in infancy and early childhood. BMJ 2012;345:e5931.
  25. Gopel W, Kribs A, Ziegler A, et al: Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011;378:1627-1634.
  26. Arnold CC, Kramer MS, Hobbs CA, McLean FH, Usher RH: Very low birth weight: a problematic cohort for epidemiologic studies of very small or immature neonates. Am J Epidemiol 1991;134:604-613.

    External Resources

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50